A former prostate cancer patient who got the all-clear said taking part in a trial that cut his radiotherapy treatments ...

The use of magnetic resonance–guided daily adaptive stereotactic body radiotherapy (SBRT) for patients with prostate cancer reduces the risk of acute urinary side effects of grade 2 or higher by 44% ...

CURE spoke with an expert about the potential positive effects of radiation therapy for patients with hepatocellular carcinoma. CURE recently spoke with Dr. Laura Dawson, a professor and chair of the ...

For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Magnetic ...

SBRT demonstrates high local control rates for larger RCC tumors, outperforming other ablative methods in terms of efficacy and safety. All ablative methods, including radiofrequency, microwave, and ...

Regarding disease-free survival, 88.6% of patients in the SBRT group were free from disease progression after three years, compared to 92.1% receiving longer courses of radiation. The difference was ...

The phase 3 NRG GU-005 trial did not show a DFS benefit for SBRT vs IMRT in intermediate-risk prostate cancer, but SBRT decreased rectal toxicity. Stereotactic body radiation therapy (SBRT) preserves ...

Recent results from the Phase III NRG-RTOG 1112 clinical study showed that the addition of stereotactic body radiotherapy (SBRT) to systemic therapy with sorafenib significantly improved ...

HDR brachytherapy and radiotherapy as salvage treatment for macroscopic recurrence in the prostate bed after radical prostatectomy. This is an ASCO Meeting Abstract from the 2023 ASCO Genitourinary ...

A phase 2 trial supports SBRT for primary treatment of localized RCC. Stereotactic body radiotherapy (SBRT) showed favorable long-term local control and cause-specific survival (CSS) in a phase 2 ...

International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and Study We received 395 responses from radiation oncologists ...